ZeroStack Corp. ZSTK
Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Chart by TradingView
0/9
Piotroski F — financial health
-13.69
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $35.7M | $35.9M | $76.1M | $33.4M | $9.0M |
| Gross profit | $1.6M | $2.2M | $17.7M | $13.3M | $2.4M |
| Operating income | -$154.7M | -$8.9M | -$50.4M | -$47.2M | -$19.0M |
| Net income | — | -$15.9M | -$57.0M | -$52.4M | -$21.4M |
| Operating cash flow | -$8.7M | -$5.0M | -$8.4M | -$15.9M | -$20.9M |
| Free cash flow | -$8.8M | -$5.2M | -$8.6M | -$17.2M | -$24.9M |
| Total assets | $130.2M | $26.2M | $23.6M | $81.0M | $85.5M |
| Total liabilities | $59.7M | $21.7M | $17.2M | $24.6M | $8.5M |
| Shareholders' equity | $70.6M | $4.5M | $6.4M | $56.4M | $76.9M |
| Ratios | |||||
| Gross margin | 4.6% | 6.1% | 23.3% | 39.7% | 27.0% |
| Operating margin | -433.5% | -24.9% | -66.2% | -141.4% | -211.6% |
| Net margin | — | -44.4% | -75.0% | -156.9% | -237.9% |
| FCF margin | -24.7% | -14.4% | -11.3% | -51.6% | -277.5% |
| Return on assets | — | -60.7% | -241.4% | -64.7% | -25.0% |
| Return on equity | — | -352.7% | -890.6% | -92.9% | -27.8% |
| Debt / equity | 0.76× | 0.00× | — | — | — |
| Current ratio | 1.01 | 1.05 | 1.31 | 1.79 | 7.84 |
| Revenue growth | -0.5% | -52.9% | 127.8% | 271.9% | — |
Why these scores methodology →
Piotroski F-score: 0/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -13.69 (distress)
- Working capital / assets 0.001
- Retained earnings / assets -2.133
- EBIT / assets -1.187
- Equity / liabilities 1.182
Sector peers
MCK · CAH · SYY · PFGC · SNX · INGM · all Wholesale Trade →
Source: SEC EDGAR filings · CIK 0001790169 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.